Fenwick Represents ZipDrug in Acquisition by IngenioRx

Fenwick represented ZipDrug, an innovative pharmacy management company focused on improving the quality of pharmacy care, in its acquisition by IngenioRx, a wholly owned subsidiary of Anthem, Inc.

This acquisition expands upon IngenioRx’s existing capabilities that focus on simplifying care and bringing clarity to costs. More information can be obtained from IngenioRx’s announcement.

The Fenwick transaction team included corporate partners Ian Goldstein and Ethan Skerry and associates Sean Childers, Jonathan Allan, Lisa Richards, Han Ko and Jamal Johnson; executive compensation & employee benefits partner Gerald Audant, of counsel Mona Clee and counsel Laura McIntyre; employment practices counsel Matthew Damm; technology transactions partner Jonathan Millard and associate Pinar Bailey; and tax partner Larissa Neumann and associate Michael Knobler.